In The News Posted February 1, 2019 Share Posted February 1, 2019 GOTHENBURG, Sweden, Feb. 1, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced that all senior executives and employees participated in Isofol's share warrant program "2018" (series 2018/2022 and series 2018/2023). A total of 1,260,139... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.